From 2013 to 2023, the import of composite diagnostic or laboratory reagents to China has shown a robust upward trend, rising from $1.0425 billion to $2.1666 billion. The annual year-on-year growth rates have fluctuated, peaking at 28.35% in 2016, followed by a more tempered increase in subsequent years. The Compound Annual Growth Rate (CAGR) over the last five years has diminished from 11.36% in 2018 to 3.94% in 2023.

Crucially, between 2022 and 2023, the growth rate decreased slightly from 4.31% to 4.05%. Projections indicate a continued but slower growth rate with a 5-year CAGR forecasted at 2.65%, reaching $2.5639 billion by 2028, reflecting a predicted 13.99% overall growth over five years.

Future trends to watch for include:

Technological advancements leading to more sophisticated and potentially costlier diagnostic reagents
Policy changes in China affecting import regulations and market accessibility
Potential shifts due to global supply chain dynamics and geopolitical developments